1. Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox. Issue 1 (January 2021) Authors: Dubsky, Peter; Pinker, Katja; Cardoso, Fatima; Montagna, Giacomo; Ritter, Mathilde; Denkert, Carsten; Rubio, Isabel T; de Azambuja, Evandro; Curigliano, Giuseppe; Gentilini, Oreste; Gnant, Michael; Günthert, Andreas; Hauser, Nik; Heil, Joerg; Knauer, Michael; Knotek-Roggenbauerc, Mona; Knox, Susa... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: e18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Contrast of Digital and Health Literacy Between IT and Health Care Specialists Highlights the Importance of Multidisciplinary Teams for Digital Health—A Pilot Study. (2021) Authors: Pfob, André; Sidey-Gibbons, Chris; Schuessler, Maximilian; Lu, Sheng-Chieh; Xu, Cai; Dubsky, Peter; Golatta, Michael; Heil, Joerg Journal: JCO Clinical Cancer Informatics Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Germline TP53 pathogenic variants and breast cancer: A narrative review. (March 2023) Authors: Blondeaux, Eva; Arecco, Luca; Punie, Kevin; Graffeo, Rossella; Toss, Angela; De Angelis, Carmine; Trevisan, Lucia; Buzzatti, Giulia; Linn, Sabine C.; Dubsky, Peter; Cruellas, Mara; Partridge, Ann H.; Balmaña, Judith; Paluch-Shimon, Shani; Lambertini, Matteo Journal: Cancer treatment reviews Issue: Volume 114(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by Pfob et al. (January 2021) Authors: Dubsky, Peter; Tausch, Christoph Journal: European journal of cancer Issue: Volume 143(2021) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of Her‐2‐Targeted Therapy on Overall Survival in Patients With Her‐2 Positive Metastatic Breast Cancer. Issue 2 (27th January 2013) Authors: Berghoff, Anna S.; Bago‐Horvath, Zsuzsanna; Dubsky, Peter; Rudas, Margaretha; Pluschnig, Ursula; Wiltschke, Christoph; Gnant, Michael; Steger, Guenther G.; Zielinski, Christoph C.; Bartsch, Rupert Journal: Breast journal Issue: Volume 19:Issue 2(2013:Mar./Apr.) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients. Issue 2 (February 2019) Authors: Tahmassebi, Amirhessam; Wengert, Georg J.; Helbich, Thomas H.; Bago-Horvath, Zsuzsanna; Alaei, Sousan; Bartsch, Rupert; Dubsky, Peter; Baltzer, Pascal; Clauser, Paola; Kapetas, Panagiotis; Morris, Elizabeth A.; Meyer-Baese, Anke; Pinker, Katja Journal: Investigative radiology Issue: Volume 54:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Management of the Nipple-Areola Complex in Selected Patients Undergoing Primary Breast Reconstruction: A Comparison of Immediate Replantation and Delayed Reconstruction. Issue 4 (April 2017) Authors: Nedomansky, Jakob; Nickl, Stefanie; Maier, Bernhard; Dubsky, Peter; Haslik, Werner; Schroegendorfer, Klaus F. Journal: Annals of plastic surgery Issue: Volume 78:Issue 4(2017:Apr.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Issue 9 (September 2019) Authors: Saura, Cristina; Hlauschek, Dominik; Oliveira, Mafalda; Zardavas, Dimitrios; Jallitsch-Halper, Anita; de la Peña, Lorena; Nuciforo, Paolo; Ballestrero, Alberto; Dubsky, Peter; Lombard, Janine M; Vuylsteke, Peter; Castaneda, Carlos A; Colleoni, Marco; Santos Borges, Giuliano; Ciruelos, Eva; Fornie... Journal: Lancet oncology Issue: Volume 20:Issue 9(2019) Page Start: 1226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. New approaches for breast cancer: should Ret kinase be considered as a novel therapeutic target?. (February 2014) Authors: Kenner, Lukas; Birner, Peter; Bartsch, Rupert; Schreiber, Martin; Dubsky, Peter Journal: Future oncology Issue: Volume 10:Number 3(2014) Page Start: 333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. New approaches for breast cancer: should Ret kinase be considered as a novel therapeutic target?. (February 2014) Authors: Birner, Peter; Bartsch, Rupert; Schreiber, Martin; Dubsky, Peter; Kenner, Lukas Journal: Future oncology Issue: Volume 10:Number 3(2014) Page Start: 333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗